Literature DB >> 20629132

A novel X-linked four-repeat tauopathy with Parkinsonism and spasticity.

Parvoneh Poorkaj1, Wendy H Raskind, James B Leverenz, Mark Matsushita, Cyrus P Zabetian, Ali Samii, Sophia Kim, Nayiry Gazi, John G Nutt, John Wolff, Dora Yearout, J Lynne Greenup, Ellen J Steinbart, Thomas D Bird.   

Abstract

The parkinsonian syndromes comprise a highly heterogeneous group of disorders. Although 15 loci are linked to predominantly familial Parkinson's disease (PD), additional PD loci are likely to exist. We recently identified a multigenerational family of Danish and German descent in which five males in three generations presented with a unique syndrome characterized by parkinsonian features and variably penetrant spasticity for which X-linked disease transmission was strongly suggested (XPDS). Autopsy in one individual failed to reveal synucleinopathy; however, there was a significant four-repeat tauopathy in the striatum. Our objective was to identify the locus responsible for this unique parkinsonian disorder. Members of the XPDS family were genotyped for markers spanning the X chromosome. Two-point and multipoint linkage analyses were performed and the candidate region refined by analyzing additional markers. A multipoint LOD(max) score of 2.068 was obtained between markers DXS991 and DXS993. Haplotype examination revealed an approximately 20 cM region bounded by markers DXS8042 and DXS1216 that segregated with disease in all affected males and obligate carrier females and was not carried by unaffected at-risk males. To reduce the possibility of a false-positive linkage result, multiple loci and genes associated with other parkinsonian or spasticity syndromes were excluded. In conclusion, we have identified a unique X-linked parkinsonian syndrome with variable spasticity and four-repeat tau pathology, and defined a novel candidate gene locus spanning approximately 28 Mb from Xp11.2-Xq13.3. (c) 2010 Movement Disorder Society.

Entities:  

Mesh:

Year:  2010        PMID: 20629132      PMCID: PMC3123999          DOI: 10.1002/mds.23085

Source DB:  PubMed          Journal:  Mov Disord        ISSN: 0885-3185            Impact factor:   10.338


  34 in total

1.  Parametric and nonparametric multipoint linkage analysis with imprinting and two-locus-trait models: application to mite sensitization.

Authors:  K Strauch; R Fimmers; T Kurz; K A Deichmann; T F Wienker; M P Baur
Journal:  Am J Hum Genet       Date:  2000-05-04       Impact factor: 11.025

2.  Pallido-pyramidal disease.

Authors:  C DAVISON
Journal:  J Neuropathol Exp Neurol       Date:  1954-01       Impact factor: 3.685

3.  Intention tremor, parkinsonism, and generalized brain atrophy in male carriers of fragile X.

Authors:  R J Hagerman; M Leehey; W Heinrichs; F Tassone; R Wilson; J Hills; J Grigsby; B Gage; P J Hagerman
Journal:  Neurology       Date:  2001-07-10       Impact factor: 9.910

4.  Genotype in the 24-kDa subunit gene (NDUFV2) of mitochondrial complex I and susceptibility to Parkinson disease.

Authors:  N Hattori; H Yoshino; M Tanaka; H Suzuki; Y Mizuno
Journal:  Genomics       Date:  1998-04-01       Impact factor: 5.736

5.  Variations in the monoamine oxidase B (MAOB) gene are associated with Parkinson's disease.

Authors:  G D Mellick; D D Buchanan; S J McCann; K M James; A G Johnson; D R Davis; N Liyou; D Chan; D G Le Couteur
Journal:  Mov Disord       Date:  1999-03       Impact factor: 10.338

6.  Corticobasal degeneration and progressive supranuclear palsy share a common tau haplotype.

Authors:  H Houlden; M Baker; H R Morris; N MacDonald; S Pickering-Brown; J Adamson; A J Lees; M N Rossor; N P Quinn; A Kertesz; M N Khan; J Hardy; P L Lantos; P St George-Hyslop; D G Munoz; D Mann; A E Lang; C Bergeron; E H Bigio; I Litvan; K P Bhatia; D Dickson; N W Wood; M Hutton
Journal:  Neurology       Date:  2001-06-26       Impact factor: 9.910

7.  A quantitative-trait analysis of human plasma-dopamine beta-hydroxylase activity: evidence for a major functional polymorphism at the DBH locus.

Authors:  C P Zabetian; G M Anderson; S G Buxbaum; R C Elston; H Ichinose; T Nagatsu; K S Kim; C H Kim; R T Malison; J Gelernter; J F Cubells
Journal:  Am J Hum Genet       Date:  2001-01-19       Impact factor: 11.025

Review 8.  Consensus recommendations for the postmortem diagnosis of Alzheimer's disease. The National Institute on Aging, and Reagan Institute Working Group on Diagnostic Criteria for the Neuropathological Assessment of Alzheimer's Disease.

Authors: 
Journal:  Neurobiol Aging       Date:  1997 Jul-Aug       Impact factor: 4.673

9.  Comprehensive human genetic maps: individual and sex-specific variation in recombination.

Authors:  K W Broman; J C Murray; V C Sheffield; R L White; J L Weber
Journal:  Am J Hum Genet       Date:  1998-09       Impact factor: 11.025

10.  LRRK2 mutations and risk variants in Japanese patients with Parkinson's disease.

Authors:  Cyrus P Zabetian; Mitsutoshi Yamamoto; Alexis N Lopez; Hiroshi Ujike; Ignacio F Mata; Yuishin Izumi; Ryuji Kaji; Hirofumi Maruyama; Hiroyuki Morino; Masaya Oda; Carolyn M Hutter; Karen L Edwards; Gerard D Schellenberg; Debby W Tsuang; Dora Yearout; Eric B Larson; Hideshi Kawakami
Journal:  Mov Disord       Date:  2009-05-15       Impact factor: 10.338

View more
  8 in total

1.  ATP6AP2 variant impairs CNS development and neuronal survival to cause fulminant neurodegeneration.

Authors:  Takuo Hirose; Alfredo Cabrera-Socorro; David Chitayat; Thomas Lemonnier; Olivier Féraud; Carmen Cifuentes-Diaz; Nicolas Gervasi; Cedric Mombereau; Tanay Ghosh; Loredana Stoica; Jeanne d'Arc Al Bacha; Hiroshi Yamada; Marcel A Lauterbach; Marc Guillon; Kiriko Kaneko; Joy W Norris; Komudi Siriwardena; Susan Blasér; Jérémie Teillon; Roberto Mendoza-Londono; Marion Russeau; Julien Hadoux; Sadayoshi Ito; Pierre Corvol; Maria G Matheus; Kenton R Holden; Kohji Takei; Valentina Emiliani; Annelise Bennaceur-Griscelli; Charles E Schwartz; Genevieve Nguyen; Matthias Groszer
Journal:  J Clin Invest       Date:  2019-04-15       Impact factor: 14.808

Review 2.  Disorders of lysosomal acidification-The emerging role of v-ATPase in aging and neurodegenerative disease.

Authors:  Daniel J Colacurcio; Ralph A Nixon
Journal:  Ageing Res Rev       Date:  2016-05-16       Impact factor: 10.895

3.  Altered splicing of ATP6AP2 causes X-linked parkinsonism with spasticity (XPDS).

Authors:  Olena Korvatska; Nicholas S Strand; Jason D Berndt; Tim Strovas; Dong-Hui Chen; James B Leverenz; Konstantin Kiianitsa; Ignacio F Mata; Emre Karakoc; J Lynne Greenup; Emily Bonkowski; Joseph Chuang; Randall T Moon; Evan E Eichler; Deborah A Nickerson; Cyrus P Zabetian; Brian C Kraemer; Thomas D Bird; Wendy H Raskind
Journal:  Hum Mol Genet       Date:  2013-04-16       Impact factor: 6.150

4.  Classification of diseases with accumulation of Tau protein.

Authors:  Gabor G Kovacs; Bernardino Ghetti; Michel Goedert
Journal:  Neuropathol Appl Neurobiol       Date:  2022-02-09       Impact factor: 6.250

5.  Conditional depletion of intellectual disability and Parkinsonism candidate gene ATP6AP2 in fly and mouse induces cognitive impairment and neurodegeneration.

Authors:  Aline Dubos; Anna Castells-Nobau; Hamid Meziane; Merel A W Oortveld; Xander Houbaert; Giovanni Iacono; Christelle Martin; Christophe Mittelhaeuser; Valérie Lalanne; Jamie M Kramer; Anuradha Bhukel; Christine Quentin; Jan Slabbert; Patrik Verstreken; Stefan J Sigrist; Nadia Messaddeq; Marie-Christine Birling; Mohammed Selloum; Henk G Stunnenberg; Yann Humeau; Annette Schenck; Yann Herault
Journal:  Hum Mol Genet       Date:  2015-09-16       Impact factor: 6.150

6.  Loss of zebrafish atp6v1e1b, encoding a subunit of vacuolar ATPase, recapitulates human ARCL type 2C syndrome and identifies multiple pathobiological signatures.

Authors:  Lore Pottie; Wouter Van Gool; Michiel Vanhooydonck; Franz-Georg Hanisch; Geert Goeminne; Andreja Rajkovic; Paul Coucke; Patrick Sips; Bert Callewaert
Journal:  PLoS Genet       Date:  2021-06-18       Impact factor: 5.917

7.  Essential role of ATP6AP2 enrichment in caveolae/lipid raft microdomains for the induction of neuronal differentiation of stem cells.

Authors:  Nehman Makdissy; Katia Haddad; Jeanne D'arc AlBacha; Diana Chaker; Bassel Ismail; Albert Azar; Ghada Oreibi; David Ayoub; Ibrahim Achkar; Didier Quilliot; Ziad Fajloun
Journal:  Stem Cell Res Ther       Date:  2018-05-11       Impact factor: 6.832

Review 8.  Tau Pathology in Parkinson's Disease.

Authors:  Xue Zhang; Fei Gao; Dongdong Wang; Chao Li; Yi Fu; Wei He; Jianmin Zhang
Journal:  Front Neurol       Date:  2018-10-02       Impact factor: 4.003

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.